Osteoporosis News

The FDA has approved two new biosimilars of denosumab to treat osteoporosis, increase bone mass, prevent skeletal-related events for people with multiple myeloma and other indications, Samsung Bioepis announced.

Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than those receiving placebo, according to trial findings published in The New England Journal of Medicine.

In a final recommendation statement, the U.S. Preventive Services Task Force said that all women aged 65 years and older should be screened for osteoporosis to prevent fractures.

Having GERD, diabetes or osteoporosis in addition to COPD heightened the likelihood for exacerbations, ED visits and hospitalizations, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

Fractures that occurred during adulthood were associated with risk for future fractures, regardless of age of fracture occurrence, according to cohort study results published in JAMA Network Open.

WASHINGTON — Although even low-dose prednisone significantly increases the risk for fracture in systemic lupus erythematosus, there is no increased risk from intramuscular triamcinolone or intravenous methylprednisolone, said a speaker.

Patients with systemic sclerosis demonstrate lower bone mineral density compared with the general population, with significant differences reported in women aged younger than 45 years, according to data published in Rheumatology.

According to published results, severe mental illnesses, such as schizophrenia and bipolar disorder, may be risk factors for decreased bone mineral density, fragility fractures and undiagnosed osteoporosis.

A novel clinical prediction model accurately assessed the 5-year hip fracture risk among the Swedish population without data on bone density, according to published results.